• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

丁酰胆碱酯酶与丙酰普罗嗪对映体立体选择性相互作用的机制。

Mechanism of stereoselective interaction between butyrylcholinesterase and ethopropazine enantiomers.

机构信息

Institute for Medical Research and Occupational Health, POB 291, HR-10001 Zagreb, Croatia.

出版信息

Biochimie. 2011 Oct;93(10):1797-807. doi: 10.1016/j.biochi.2011.06.023. Epub 2011 Jun 29.

DOI:10.1016/j.biochi.2011.06.023
PMID:21740955
Abstract

Stereoselectivity of reversible inhibition of butyrylcholinesterase (BChE; EC 3.1.1.8) by optically pure ethopropazine [10-(2-diethylaminopropyl)phenothiazine hydrochloride] enantiomers and racemate was studied with acetylthiocholine (0.002-250 mM) as substrate. Molecular modelling resulted in the reaction between BChE and ethopropazine starting with the binding of ethopropazine to the enzyme peripheral anionic site. In the next step ethopropazine 'slides down' the enzyme gorge, resulting in interaction of the three rings of ethopropazine through π-π interactions with W82 in BChE. Inhibition mechanism was interpreted according to three kinetic models: A, B and C. The models differ in the type and number of enzyme-substrate, enzyme-inhibitor and enzyme-substrate-inhibitor complexes, i.e., presence of the Michaelis complex and/or acetylated BChE. Although, all three models reproduced well the BChE activity in absence of ethopropazine, model A was poor in describing inhibition with ethopropazine, while models B and C were better, especially for substrate concentrations above 0.2 mM. However model C was singled out because it approaches fulfilment of the one step-one event criteria, and confirms the inhibition mechanism derived from molecular modelling. Model C resulted in dissociation constants for the complex between BChE and ethopropazine: 61, 140 and 88 nM for R-enantiomer, S-enantiomer and racemate, respectively. The respective dissociation constants for the complexes between acetylated BChE and ethopropazine were 268, 730 and 365 nM. Butyrylcholinesterase had higher affinity for R-ethopropazine.

摘要

立体选择性的可逆抑制丁酰胆碱酯酶(BChE; EC 3.1.1.8)由光学纯的丙嗪[10-(2-二乙氨基丙基)吩噻嗪盐酸盐]对映异构体和外消旋体进行研究,以乙酰硫代胆碱(0.002-250 mM)为底物。分子模拟导致 BChE 与丙嗪反应,从丙嗪与酶外周阴离子结合开始。在下一个步骤中,丙嗪“向下滑动”酶峡谷,导致丙嗪的三个环通过与 BChE 中的 W82 的π-π相互作用相互作用。根据三种动力学模型解释抑制机制:A、B 和 C。这些模型在酶-底物、酶-抑制剂和酶-底物-抑制剂复合物的类型和数量上有所不同,即存在米氏复合物和/或乙酰化的 BChE。虽然所有三种模型都很好地再现了没有丙嗪时 BChE 的活性,但模型 A 在描述丙嗪抑制时效果不佳,而模型 B 和 C 更好,特别是在底物浓度高于 0.2 mM 时。然而,模型 C 被挑出来,因为它接近满足一步一事件的标准,并证实了从分子模拟得出的抑制机制。模型 C 导致 BChE 与丙嗪之间复合物的离解常数:R-对映体、S-对映体和外消旋体分别为 61、140 和 88 nM。乙酰化的 BChE 与丙嗪之间复合物的相应离解常数分别为 268、730 和 365 nM。丁酰胆碱酯酶对 R-丙嗪具有更高的亲和力。

相似文献

1
Mechanism of stereoselective interaction between butyrylcholinesterase and ethopropazine enantiomers.丁酰胆碱酯酶与丙酰普罗嗪对映体立体选择性相互作用的机制。
Biochimie. 2011 Oct;93(10):1797-807. doi: 10.1016/j.biochi.2011.06.023. Epub 2011 Jun 29.
2
Kinetic model of ethopropazine interaction with horse serum butyrylcholinesterase and its docking into the active site.乙丙嗪与马血清丁酰胆碱酯酶相互作用的动力学模型及其对接至活性位点
Arch Biochem Biophys. 2002 Feb 1;398(1):23-31. doi: 10.1006/abbi.2001.2697.
3
Differences in active-site gorge dimensions of cholinesterases revealed by binding of inhibitors to human butyrylcholinesterase.抑制剂与人类丁酰胆碱酯酶结合揭示的胆碱酯酶活性位点峡谷尺寸差异。
Chem Biol Interact. 1999 May 14;119-120:61-9. doi: 10.1016/s0009-2797(99)00014-9.
4
Stereoselective inhibition of human, mouse, and horse cholinesterases by bambuterol enantiomers.班布特罗对映体对人、小鼠和马胆碱酯酶的立体选择性抑制作用。
Chem Biol Interact. 2008 Sep 25;175(1-3):192-5. doi: 10.1016/j.cbi.2008.04.050. Epub 2008 May 21.
5
Differences in active site gorge dimensions of cholinesterases revealed by binding of inhibitors to human butyrylcholinesterase.抑制剂与人类丁酰胆碱酯酶结合所揭示的胆碱酯酶活性位点峡谷尺寸差异。
Biochemistry. 1997 Dec 2;36(48):14642-51. doi: 10.1021/bi971425+.
6
Kinetic analysis of effector modulation of butyrylcholinesterase-catalysed hydrolysis of acetanilides and homologous esters.丁酰胆碱酯酶催化乙酰苯胺及其同系酯水解的效应物调节的动力学分析
FEBS J. 2008 May;275(10):2617-31. doi: 10.1111/j.1742-4658.2008.06409.x. Epub 2008 Apr 15.
7
Peripheral site and acyl pocket define selective inhibition of mouse butyrylcholinesterase by two biscarbamates.两个双氨基甲酸酯通过外周结合部位和酰基结合口袋选择性抑制小鼠丁酰胆碱酯酶。
Arch Biochem Biophys. 2013 Jan 15;529(2):140-5. doi: 10.1016/j.abb.2012.11.012. Epub 2012 Dec 3.
8
Stereoselective inhibition of human butyrylcholinesterase by the enantiomers of bambuterol and their intermediates.班布特罗对映体及其中间体对人丁酰胆碱酯酶的立体选择性抑制作用。
Drug Metab Dispos. 2015 Mar;43(3):344-52. doi: 10.1124/dmd.114.060251. Epub 2014 Dec 11.
9
Amino acid residues involved in stereoselective inhibition of cholinesterases with bambuterol.参与班布特罗对胆碱酯酶立体选择性抑制作用的氨基酸残基。
Arch Biochem Biophys. 2008 Mar 1;471(1):72-6. doi: 10.1016/j.abb.2007.12.007. Epub 2007 Dec 23.
10
Hysteresis of butyrylcholinesterase in the approach to steady-state kinetics.丁酰胆碱酯酶在接近稳态动力学过程中的滞后现象。
Chem Biol Interact. 2005 Dec 15;157-158:143-52. doi: 10.1016/j.cbi.2005.10.019. Epub 2005 Oct 27.

引用本文的文献

1
Cholesterol Oxime Olesoxime Assessed as a Potential Ligand of Human Cholinesterases.胆固醇肟类化合物 Oleoxime 被评估为人类胆碱酯酶的潜在配体。
Biomolecules. 2024 May 15;14(5):588. doi: 10.3390/biom14050588.
2
A novel RP-HPLC method for quantification of cholinesterase activity in human blood: An application for assessing organophosphate and carbamate insecticide exposure.一种用于定量人血液中胆碱酯酶活性的新型反相高效液相色谱法:一种评估有机磷和氨基甲酸酯类杀虫剂暴露的应用。
PLoS One. 2022 Dec 30;17(12):e0279287. doi: 10.1371/journal.pone.0279287. eCollection 2022.
3
Benzobicyclo[3.2.1]octene Derivatives as a New Class of Cholinesterase Inhibitors.
苯并双环[3.2.1]辛烯衍生物作为一类新型的胆碱酯酶抑制剂。
Molecules. 2020 Oct 22;25(21):4872. doi: 10.3390/molecules25214872.
4
Synthesis and In Vitro Screening of Novel Heterocyclic β-d-Gluco- and β-d-Galactoconjugates as Butyrylcholinesterase Inhibitors.新型杂环β-d-葡萄糖和β-d-半乳糖苷作为丁酰胆碱酯酶抑制剂的合成及体外筛选。
Molecules. 2019 Aug 4;24(15):2833. doi: 10.3390/molecules24152833.
5
Design and evaluation of selective butyrylcholinesterase inhibitors based on Cinchona alkaloid scaffold.基于金鸡纳生物碱骨架的选择性丁酰胆碱酯酶抑制剂的设计与评价。
PLoS One. 2018 Oct 5;13(10):e0205193. doi: 10.1371/journal.pone.0205193. eCollection 2018.
6
Comparison of the Binding of Reversible Inhibitors to Human Butyrylcholinesterase and Acetylcholinesterase: A Crystallographic, Kinetic and Calorimetric Study.比较可逆抑制剂与人丁酰胆碱酯酶和乙酰胆碱酯酶的结合:晶体学、动力学和量热研究。
Molecules. 2017 Nov 29;22(12):2098. doi: 10.3390/molecules22122098.
7
Characterization of butyrylcholinesterase in bovine serum.牛血清中丁酰胆碱酯酶的特性分析。
Chem Biol Interact. 2017 Mar 25;266:17-27. doi: 10.1016/j.cbi.2017.02.004. Epub 2017 Feb 8.
8
First chemoenzymatic stereodivergent synthesis of both enantiomers of promethazine and ethopropazine.首次通过酶促立体发散合成法合成了普罗米嗪和乙氧普嗪的对映异构体。
Beilstein J Org Chem. 2014 Dec 18;10:3038-55. doi: 10.3762/bjoc.10.322. eCollection 2014.
9
Predicting nonlinear pharmacokinetics of omeprazole enantiomers and racemic drug using physiologically based pharmacokinetic modeling and simulation: application to predict drug/genetic interactions.使用基于生理的药代动力学建模与模拟预测奥美拉唑对映体和外消旋药物的非线性药代动力学:用于预测药物/基因相互作用的应用
Pharm Res. 2014 Aug;31(8):1919-29. doi: 10.1007/s11095-013-1293-z. Epub 2014 Mar 4.
10
Probing the peripheral site of human butyrylcholinesterase.探究人丁酰胆碱酯酶的外周结合部位。
Biochemistry. 2012 Sep 11;51(36):7046-53. doi: 10.1021/bi300955k. Epub 2012 Aug 27.